Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Fragmentation of Care in Ectopic Pregnancy.
LTR-mediated retroposition as a mechanism of RNA-based duplication in metazoans.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis. N Engl J Med. 2015 Jul 09; 373(2):136-44.
View in:
PubMed
subject areas
Adalimumab
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
Dose-Response Relationship, Drug
Double-Blind Method
Female
Follow-Up Studies
Humans
Injections, Subcutaneous
Interleukin-23
Male
Middle Aged
Psoriasis
Severity of Illness Index
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
Kenneth Gordon